Art

J-GLOBAL ID：200902279183945471   Reference number：08A0585895

Cell Behavior Analysis to Evaluate Proliferative Potentials of Human Lymphocytes Expanded and Activated for Therapeutic Use

治療利用のために拡張および活性化されたヒトリンパ球の増殖能を評価するための細胞挙動解析

Author (4)： HATA Norihiko (Medinet Medical Inst., Medinet Co., Ltd.) ,  JINGUJI Hidemasa (Medinet Medical Inst., Medinet Co., Ltd.) ,  KINO-OKA Masahiro (Div. of Chemical Engineering, Graduate School of Engineering Sci., Osaka Univ.) ,  TAYA Masahito (Div. of Chemical Engineering, Graduate School of Engineering Sci., Osaka Univ.)
Material： Journal of Bioscience and Bioengineering  (J Biosci Bioeng)
Volume： 105  Issue： 5  Page： 566-569 (J-STAGE)  Publication year： 2008 
JST Material Number： G0535B  ISSN： 1389-1723  CODEN： JBBIF6  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *lymphocyte ,...
Semi thesaurus term： Killer Cells ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0585895&from=J-GLOBAL&jstjournalNo=G0535B") }}

JST classification (1)： Cell and tissue culture methods  (EA03040R)

Reference (14)：

• 1. Egawa, K.: Immuno-cell therapy of cancer in Japan. Anticancer Res., 24, 3321–3326 (2004).
• 2. Rosenberg, S. A., Lotze, M. T., Muul, L. M., Leitman, S., Chang, A. E., Ettinghausen, S. E., Matory, Y. L., Skibber, J. M., Shiloni, E., Vetto, J. T., Seipp, C. A., Simpson, C., and Reichert, C. M.: Observations on the systematic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med., 313, 1485–1492 (1985).
• 3. Rosenberg, S. A., Lotze, M. T., Muul, L. M., Chang, A. E., Avis, F. P., Leitman, S., Linehan, W. M., Robertson, C. N., Lee, R. E., Rubin, J. T., Seipp, C. A., Simpson, C. G., and White, D. E.: A progress report of the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high dose interleukin-2 alone. N. Engl. J. Med., 316, 889–897 (1987).
• 4. Rosenberg, S. A., Lotze, M. T., Yang, J. C., Topalin, S. L., Chang, A. E., Schwartzentruber, D. J., Aebersold, P., Leitman, S., Linehan, W. M., Seipp, C. A., White, D. E., and Steinberg, S. M.: Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancer. J. Natl. Cancer Inst., 85, 622–632 (1993).
• 5. Mason, C. and Hoare, M.: Regenerative medicine bioprocessing: building a conceptual framework based on early studies. Tissue Eng., 13, 301–311 (2007).

Terms in the title (9)： 治療 ,  拡張 ,  活性化 ,  ヒト ,  リンパ球 ,  増殖能 ,  評価 ,  細胞挙動 ,  解析